Strides Pharma Science Limited
₹1,415.3
INR+26.45(+1.90%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹14028.22 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹15735.20 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
78.59
Forward P/E
Price to Earnings ratio based on forecasted earnings
24.04
PEG Ratio
Price/Earnings to Growth ratio
24.04
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.18
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
58.54%
Operating Margin
Operating income as a percentage of revenue
15.43%
Return on Equity
Net income as a percentage of shareholders' equity
8.19%
Revenue (TTM)
Total revenue over trailing 12 months
₹4410.32 Cr+20.200000000000003%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹713.30 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹19.410
Balance Sheet
Total Cash
Total cash and short-term investments
₹246.99 Cr
Total Debt
Total short-term and long-term debt
₹2308.49 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
104.22%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹467 - ₹1675
Beta
Measure of stock's volatility compared to the market
0.80
Shares Outstanding
Total number of shares issued by the company
₹9.20 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.64%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
12.91%